Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcitabine vs Gemcitabine + Docetaxel in Soft Tissue Sarcoma
NCT00142571Phase 3Completed
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Jan 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of docetaxel in soft tissue sarcoma (STS), sponsored by Memorial Sloan Kettering Cancer Center. Started Jan 2003; status: completed.
02
Drugs
docetaxel
03
Conditions
soft tissue sarcoma (STS)
Beyond the preview
Go deeper on NCT00142571.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00142571.